JPH0191759A - Gelatinous food - Google Patents
Gelatinous foodInfo
- Publication number
- JPH0191759A JPH0191759A JP62245875A JP24587587A JPH0191759A JP H0191759 A JPH0191759 A JP H0191759A JP 62245875 A JP62245875 A JP 62245875A JP 24587587 A JP24587587 A JP 24587587A JP H0191759 A JPH0191759 A JP H0191759A
- Authority
- JP
- Japan
- Prior art keywords
- food
- protein
- water
- gel
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 49
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 230000002378 acidificating effect Effects 0.000 claims abstract description 6
- 239000000679 carrageenan Substances 0.000 claims abstract description 6
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 6
- 229920001525 carrageenan Polymers 0.000 claims abstract description 6
- 229940113118 carrageenan Drugs 0.000 claims abstract description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 6
- 235000013325 dietary fiber Nutrition 0.000 claims description 18
- 235000018102 proteins Nutrition 0.000 claims description 12
- 235000021245 dietary protein Nutrition 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 7
- 108010076119 Caseins Proteins 0.000 abstract description 6
- 102000011632 Caseins Human genes 0.000 abstract description 6
- 150000001720 carbohydrates Chemical class 0.000 abstract description 6
- 229940080237 sodium caseinate Drugs 0.000 abstract description 4
- 239000000835 fiber Substances 0.000 abstract 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 229940071162 caseinate Drugs 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 235000008429 bread Nutrition 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010020710 Hyperphagia Diseases 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 235000020830 overeating Nutrition 0.000 description 4
- 239000004278 EU approved seasoning Substances 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 235000012794 white bread Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、ゲル状食品に関する。本発明のゲル状食品は
、糖尿病患者耐糖能の低下した患者における血糖値の急
激な上昇を防止するための食品として使用される。さら
に、本ゲル状食品は、過食の防止用食品として使用され
る。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to gel-like foods. The gel-like food of the present invention is used as a food for preventing rapid increases in blood sugar levels in diabetic patients with decreased glucose tolerance. Furthermore, this gel-like food is used as a food for preventing overeating.
[従来の技術および問題点コ
糖尿病などの耐糖能不全を伴う疾患の患者の耐糖能は著
しく低下しており、通常の食事を通常の方法で摂取させ
ると、血糖値が急激に上昇し、高血糖症状を呈する。こ
れは血糖上昇抑制作用を有するインスリンの分泌不全や
インスリンの作用低下によるものであり、このような症
状はひいては網膜症、腎障害、意識障害などの様々の合
併症をひき起こす原因となる。[Conventional techniques and problems] The glucose tolerance of patients with diseases associated with glucose intolerance, such as diabetes, is markedly reduced, and when they are fed normal meals in the normal manner, their blood sugar levels rise rapidly and become high. Shows blood sugar symptoms. This is due to insufficient secretion of insulin, which has the effect of suppressing blood sugar rise, and decreased insulin action, and these symptoms can lead to various complications such as retinopathy, kidney damage, and impaired consciousness.
従って急激な血糖値の上昇を防止するために、糖尿病患
者などに対して、必要なカロリーを何回にも分けて与え
たり、血糖上昇作用の強い少糖類の摂取制限を行なうな
どの食事療法が採られているが、患者やその家族にとっ
て煩雑である。Therefore, in order to prevent a sudden rise in blood sugar levels, dietary therapy such as giving the necessary calories in multiple doses to diabetic patients and restricting the intake of oligosaccharides, which have a strong blood sugar raising effect, is recommended. However, it is cumbersome for patients and their families.
またインスリンや血糖降下剤の使用による薬物療法もあ
るが、副作用があり望ましくない。There is also drug therapy using insulin or hypoglycemic agents, but these are undesirable due to side effects.
さらに、食物繊維にも、食後血糖上昇抑制作用があるこ
とが見出されているが、食物繊維を大量に摂取しなけれ
ばならなかったり、投与方法が異なると一定の効果が得
られなかったりで、未だ商品化の段階まで研究が進んで
いない。Furthermore, dietary fiber has been found to have the effect of suppressing postprandial blood sugar rise, but it may not be possible to obtain a certain effect if a large amount of dietary fiber must be ingested or if the administration method is different. , research has not yet progressed to the commercialization stage.
[問題点を解決するための手段]
本発明の第1の目的は、糖尿病患者等の耐糖能が低下し
た患者における急激な血糖値の上昇を防止し得る食品を
提供することにある。[Means for Solving the Problems] A first object of the present invention is to provide a food that can prevent rapid increases in blood sugar levels in patients with decreased glucose tolerance, such as diabetic patients.
本発明の第2の目的は、胃内滞留時間が長く、栄養価の
高いタンパク質を含有する肥満治療または予防に使用さ
れる過食防止用の食品を提供することにある。A second object of the present invention is to provide a food for preventing overeating, which has a long gastric residence time and contains a highly nutritious protein, which is used for obesity treatment or prevention.
かかる目的は下記の構成を有する本発明のゲル状食品に
よって達成される。This object is achieved by the gel-like food product of the present invention having the following structure.
1)水溶性食物繊維と酸性領域に等電点を有するタンパ
ク質とを5 v/v%以上含有するゲル状食品。1) A gel-like food containing 5 v/v% or more of water-soluble dietary fiber and a protein having an isoelectric point in an acidic region.
2)水溶性食物繊維が、カラギナシである第1項に記載
の食品。2) The food according to item 1, wherein the water-soluble dietary fiber is caraginata.
3)タンパク質が、カゼインまたはその塩である第1項
に記載の食品。3) The food according to item 1, wherein the protein is casein or a salt thereof.
4)水溶性食物繊維とタンパク質の重量比が1:1〜1
:20である第1項に記載の食品。4) Weight ratio of water-soluble dietary fiber and protein is 1:1-1
:20.
[発明の詳細な説明]
本発明は上記のとおり水溶性食物繊維と酸性領域に等電
点を有するタンパク質とを5 w/v%以上含有するゲ
ル状食品である。[Detailed Description of the Invention] As described above, the present invention is a gel-like food containing 5 w/v% or more of water-soluble dietary fiber and a protein having an isoelectric point in an acidic region.
本発明において、水溶性食物繊維としては、カラギナン
またはグアガムを用いることが望ましく、カラギナンが
特に望ましい。食物繊維は、糖質や脂質の代謝を改善す
る作用を有することで近年注目されている物質でもある
。In the present invention, it is desirable to use carrageenan or guar gum as the water-soluble dietary fiber, and carrageenan is particularly desirable. Dietary fiber is a substance that has received attention in recent years because of its ability to improve carbohydrate and lipid metabolism.
本発明において用いられるタンパク質は酸性領域に等電
点を有するものであってカゼインまたはその塩例えばカ
ゼインナトリウムもしくはカゼインカルシウムが望まし
い。The protein used in the present invention has an isoelectric point in the acidic region, and is preferably casein or a salt thereof such as sodium caseinate or calcium caseinate.
本発明の食品は、上記食物繊維と上記タンパク質との混
合物を5 w/v%以上の濃度となるように熱湯に溶解
したゲル状物である。上記食物繊維とタンパク質の総計
の濃度が5ν/V%以下では、ゲル化が不充分となり望
ましくない。The food of the present invention is a gel-like product prepared by dissolving a mixture of the above-mentioned dietary fiber and the above-mentioned protein in hot water to a concentration of 5 w/v% or more. If the total concentration of dietary fiber and protein is less than 5v/V%, gelation will be insufficient, which is not desirable.
また水溶性食物繊維とタンパク質との割合は、本発明の
食品がゲル状となるような割合であり、しかも本食品が
胃液と接触した際に、ゲルが強化されるような割合であ
る。The ratio of water-soluble dietary fiber to protein is such that the food of the present invention becomes gel-like, and the ratio is such that the gel is strengthened when the food comes into contact with gastric fluid.
このような割合は水溶性食物繊維およびタンパク質の種
類とその組合せによって異なるがおよそ1:1〜1:2
0重量比である。This ratio varies depending on the type and combination of water-soluble dietary fiber and protein, but is approximately 1:1 to 1:2.
The weight ratio is 0.
水溶性食物繊維に対するタンパク質の量(重量)が、1
倍より少ない場合は、本発明の食品が胃液と接触しても
ゲル化せず液状のままであり、また20倍より多くなる
とタンパク質が沈澱して水溶性食物繊維と分離し、ゲル
を形成しない。The amount (weight) of protein relative to water-soluble dietary fiber is 1
When the amount is less than 20 times, the food of the present invention does not gel and remains liquid even when it comes into contact with gastric juice, and when the amount is more than 20 times, the protein precipitates and separates from the water-soluble dietary fiber, and no gel is formed. .
本発明の食品は、胃中でさらにゲル化して、同時に摂取
した食品中の糖質の消化吸収過程への移行を遅延させる
。これによって糖尿病等の患者の血糖値の急激な上昇を
防ぐことができる。また、ゲルは胃内に滞在する他の飲
食物に含まれていた糖質を吸収して、その体内への吸収
を遅らせる。The food of the present invention further gels in the stomach, thereby delaying the transfer of carbohydrates in the simultaneously ingested food to the digestive and absorption process. This can prevent rapid increases in blood sugar levels in patients with diabetes and the like. The gel also absorbs carbohydrates from other foods and drinks that stay in the stomach, slowing their absorption into the body.
従って、消化吸収が早く、食後血糖上昇作用の強い(グ
リセミックインデックスの高い)食品、例えばパン、ケ
ーキ等に塗布して摂取すると効果が大きい。本発明の食
品は、咀噌の過程でこれら・の食品と混合された後、胃
内で胃酸と接触して全。Therefore, it is highly effective when ingested by applying it to foods that are quickly digested and absorbed and have a strong postprandial blood sugar raising effect (high glycemic index), such as bread and cakes. After the food of the present invention is mixed with these other foods during the chewing process, it comes into contact with gastric acid in the stomach and is completely absorbed.
体がゲル化し、同時に摂取した食品の胃内滞留時間を長
くして消化吸収過程への移行を遅延させる。The body gels, which also increases the residence time of ingested food in the stomach and delays the transition to the digestive and absorption process.
このことより、食後の血糖上昇を抑制することが可能と
なる。また、胃内滞留時間が長くなることにより、胃に
対して機械的伸展刺激が長時間にわたって加わり、食欲
を抑制することができ、ひいては過食の防止になる。This makes it possible to suppress postprandial blood sugar rise. Furthermore, by increasing the residence time in the stomach, mechanical stretching stimulation is applied to the stomach over a long period of time, which can suppress appetite and, in turn, prevent overeating.
本発明による食品は、呈味性が低いので、少量の調味料
、香辛料、フレーバー、甘味料などを添加することによ
って、容易に嗜好性を高めることが可能である。これら
調味料、香辛料、フレーバーは通常用いられるもののう
ち1種類または2種類以上を組合わせて用いることがで
きる。Since the food according to the present invention has a low taste, palatability can be easily increased by adding small amounts of seasonings, spices, flavors, sweeteners, etc. These seasonings, spices, and flavors can be used singly or in combination of two or more of the commonly used seasonings, spices, and flavors.
、本発明による食品は、ジャム様、ペースト様等にする
ことができる。ジャム様にする場合には、ストロベリー
、グレープフルーツ、オレンジ、レモン、ペパーミント
、ブルーベリー等のフレーバーと甘味料を用いる。甘味
料は、アスバルテ−ム、サッカリン、還元麦芽糖などの
低カロリーのものを用いることが望ましい。, the food according to the invention can be made into jam-like, paste-like, etc. When making it into a jam, flavors such as strawberry, grapefruit, orange, lemon, peppermint, blueberry, etc. and sweeteners are used. As the sweetener, it is desirable to use a low-calorie sweetener such as aspartame, saccharin, or reduced maltose.
また、本発明の範囲を逸脱しない範囲で他の栄養成分た
とえば炭水化物、ビタミン類、無機質類を加えてもよい
。Other nutritional ingredients such as carbohydrates, vitamins, and minerals may also be added without departing from the scope of the present invention.
以下実施例を示して本発明をさらに詳しく説明する。The present invention will be explained in more detail below with reference to Examples.
実施例 1
カラギナンVX−IEi(三菱アセテート■製)1gお
よびカゼインナトリウム(和光紬薬■製)4gを80℃
の熱湯100m1に溶解し本発明のゲル状食品を得た。Example 1 1 g of carrageenan VX-IEi (manufactured by Mitsubishi Acetate ■) and 4 g of sodium caseinate (manufactured by Wako Tsumugi Pharmaceutical ■) were heated at 80°C.
was dissolved in 100 ml of boiling water to obtain a gel-like food product of the present invention.
この食品に、ストロベリーエツセンス■(三栄化学工業
■製) 0.1mlとパルスイード@ 1/80(味の
素側製)3gを加え、溶解後、室温に放置し冷却した。To this food, 0.1 ml of Strawberry Essence ■ (manufactured by Sanei Chemical Industry ■) and 3 g of Pulse Eid @ 1/80 (manufactured by Ajinomoto) were added, and after dissolving, the mixture was left at room temperature to cool.
この食品30gを市販の食パン1枚に塗布し、被験者に
日中で咀噌を加えさせた後、その一部を50m1のビー
カーに吐き出させた。30 g of this food was applied to one piece of commercially available bread, and the test subjects were asked to masticate it during the day, and then spit out a portion into a 50 ml beaker.
一方、同じ市販の食パンを同じ被験者に日中で咀噌を加
えさせた後、その一部を別の50m1ビーカーに吐き出
させて対照とした。On the other hand, the same test subject chewed the same commercially available bread during the day and then spit out a portion into another 50 ml beaker to serve as a control.
両ビーカーに人工胃液(日本薬局方、崩壊試験法第1液
)を30m1ずつ加え、性状の変化を観察した。30 ml of artificial gastric fluid (Japanese Pharmacopoeia, disintegration test method liquid 1) was added to both beakers, and changes in properties were observed.
本発明の食品を塗布した食パンの咀噌物は、人工胃液と
の接触ですみやかに強固なゲル塊を形成した。一方、対
照群の食パンの咀噌物は、容易に人工胃液中に分散した
。The chewable bread coated with the food of the present invention quickly formed a firm gel mass upon contact with the artificial gastric fluid. On the other hand, the control group's white bread chews were easily dispersed in the artificial gastric fluid.
さらに、人工胃液中で形成されたゲルを取り出し、別の
50m1ビーカーに移した後、30m1の人工腸液(日
本薬局方崩壊試験法第2液)を加えたところ、容易にゲ
ルは崩壊し、人工腸液中に分散した。Furthermore, when the gel formed in the artificial gastric fluid was taken out and transferred to another 50 ml beaker and 30 ml of artificial intestinal fluid (Japanese Pharmacopoeia disintegration test method liquid 2) was added, the gel easily disintegrated and the artificial Dispersed in intestinal fluid.
実施例 2
カラギナンC5−215(三栄化学工業■製)1.5
gおよびカゼインナトリウム(和光純薬味製)3.5g
を80℃の熱湯100m1に溶解し本発明のゲル状食品
を得た。Example 2 Carrageenan C5-215 (manufactured by Sanei Chemical Industry ■) 1.5
g and sodium caseinate (manufactured by Wako Pure Condiments) 3.5 g
was dissolved in 100 ml of boiling water at 80°C to obtain a gel-like food product of the present invention.
この食品に、ビーフコンソメ調味料(富士食品■製)5
gを加えて溶解した後、室温に放置し冷却した。この食
品を、食パン1枚につき30.塗布し3枚を健常者に約
10分間で摂取させた。Add 5 pieces of beef consommé seasoning (manufactured by Fuji Foods) to this food.
After adding g and dissolving it, it was left to stand at room temperature and cooled. This food costs 30.00 yen per slice of bread. Three sheets were applied to healthy subjects and ingested over a period of about 10 minutes.
一方、対照として同じ被験者に対して、−週間後に、食
パン3枚を約10分間で摂取させた。On the other hand, as a control, the same subjects were made to ingest 3 slices of white bread in about 10 minutes after - week.
摂取前0分、および摂取終了後、30分、60分、90
分、120分、180分の時点で上腕より採血し、血糖
および血中インスリン濃度を測定した。0 minutes before intake and 30 minutes, 60 minutes, 90 minutes after intake
Blood was collected from the upper arm at 120 minutes, 120 minutes, and 180 minutes, and blood sugar and blood insulin concentrations were measured.
図に示すごとく、食パンに本発明の食品を塗布すること
により食後30分値における血糖値の上昇が抑えられた
。また、摂取後の全時点において血中インスリン濃度は
低値を示し、インスリンの節約効果が認められた。As shown in the figure, by applying the food of the present invention to bread, the increase in blood sugar level at 30 minutes after a meal was suppressed. In addition, blood insulin levels were low at all time points after ingestion, indicating an insulin-saving effect.
[発明の効果コ
以上詳述したように、本発明によるゲル状食品は、水溶
性の食物繊維と、酸性領域に等電点を有するタンパク質
とを5 w/v%以上の濃度で含有するものであり、こ
れをグリセミツクインデ・ソクスの高い食品に塗布し摂
取することにより、日中で咀哨混合され、胃内で胃酸と
接触し強固なゲル塊を形成するものである。[Effects of the Invention] As detailed above, the gel-like food according to the present invention contains water-soluble dietary fiber and a protein having an isoelectric point in an acidic region at a concentration of 5 w/v% or more. By applying this to foods high in glycemic index and ingesting it, it is mixed during the day and comes into contact with gastric acid in the stomach to form a strong gel mass.
通常摂取物の胃内滞留時間は、摂取物の粘度が大きいほ
ど長くなるので、本発明品を他の食品に、塗布して同時
に摂取すれば、当該他の食品の胃内。Normally, the residence time of an ingested substance in the stomach increases as the viscosity of the ingested substance increases. Therefore, if the product of the present invention is applied to other foods and ingested at the same time, the residence time of the other foods in the stomach increases.
滞留時間も遅延し、消化吸収過程への移行が遅れて、糖
質の体内への吸収を遅延させ、それにより急激な血糖値
の上昇を防止することができる。この点において、肥満
症患者や糖尿病患者のように耐糖が低下している患者に
おいて、食後の高血糖の発症を有効に防止し得る。The residence time is also delayed, and the transition to the digestive and absorption process is delayed, which delays the absorption of carbohydrates into the body, thereby preventing a rapid rise in blood sugar levels. In this respect, the onset of postprandial hyperglycemia can be effectively prevented in patients with decreased glucose tolerance such as obese patients and diabetic patients.
また、本発明の食品を食前に、または他の食品と一緒に
摂取すれば、他の食品は少量しか摂取しなくても胃に対
して機械的伸展刺激が長時間にわたって加わり、食欲を
抑制することができ、ひいては過食の防止になる。Furthermore, if the food of the present invention is taken before meals or together with other foods, mechanical stretching stimulation is applied to the stomach over a long period of time, suppressing appetite, even if only a small amount of the other food is taken. This can help prevent overeating.
なお、胃中で形成された本発明の食品のゲルは、腸液と
接触した場合には容易に崩壊するため、腸における栄養
成分の吸収は阻害されず、患者が栄養不良状態におちい
る危険性はない。Furthermore, since the gel of the food of the present invention formed in the stomach easily disintegrates when it comes into contact with intestinal fluid, the absorption of nutritional components in the intestine is not inhibited, and there is no risk of the patient becoming malnourished. do not have.
図は、食後30分後毎の血糖値と血中インスリン濃度を
示すグラフである。The figure is a graph showing the blood sugar level and blood insulin concentration every 30 minutes after a meal.
Claims (1)
ク質とを5w/v%以上含有するゲル状食品。 2)水溶性食物繊維が、カラギナンである特許請求の範
囲第1項に記載の食品。 3)タンパク質が、カゼインまたはその塩である特許請
求の範囲第1項に記載の食品。 4)水溶性食物繊維とタンパク質の重量比が1:1〜1
:20である特許請求の範囲第1項に記載の食品。[Scope of Claims] 1) A gel-like food containing 5 w/v% or more of water-soluble dietary fiber and a protein having an isoelectric point in an acidic region. 2) The food according to claim 1, wherein the water-soluble dietary fiber is carrageenan. 3) The food according to claim 1, wherein the protein is casein or a salt thereof. 4) Weight ratio of water-soluble dietary fiber and protein is 1:1-1
:20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62245875A JPH0191759A (en) | 1987-10-01 | 1987-10-01 | Gelatinous food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62245875A JPH0191759A (en) | 1987-10-01 | 1987-10-01 | Gelatinous food |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0191759A true JPH0191759A (en) | 1989-04-11 |
JPH0430824B2 JPH0430824B2 (en) | 1992-05-22 |
Family
ID=17140105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62245875A Granted JPH0191759A (en) | 1987-10-01 | 1987-10-01 | Gelatinous food |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0191759A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6229947A (en) * | 1985-07-31 | 1987-02-07 | Ajinomoto Co Inc | Production of gel containing hardly digestible polysaccharide |
-
1987
- 1987-10-01 JP JP62245875A patent/JPH0191759A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6229947A (en) * | 1985-07-31 | 1987-02-07 | Ajinomoto Co Inc | Production of gel containing hardly digestible polysaccharide |
Also Published As
Publication number | Publication date |
---|---|
JPH0430824B2 (en) | 1992-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6468962B1 (en) | Nutritional intervention composition for enhancing and extending satiety | |
US20220125093A1 (en) | Nutritional supplements including meal replacements and related methods | |
RU2469557C2 (en) | Use of galactooligosaccharides for increasing body insulin sensitivity | |
JP2006503105A (en) | Nutritional composition rich in leucine | |
PT1588629E (en) | Matrix-forming composition containing pectin | |
WO1988001477A1 (en) | Food composition | |
AU777573B2 (en) | Methods for suppressing appetite and enhancing exercise and recovery | |
JP2005529944A (en) | Use of pullulan as a slowly digestible carbohydrate | |
US6905702B1 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
JPS60188403A (en) | Composition | |
JP2000189109A (en) | Liquid food | |
CN106573034B (en) | Marine peptides and fish nucleotides, compositions and uses thereof for lowering blood glucose | |
JP3165743B2 (en) | Liquid food | |
WO2001033976A1 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
CA2408023C (en) | Glucosamine as a food and beverage additive | |
Zillikens et al. | Effects of the glucosidase inhibitor acarbose in patients with liver cirrhosis | |
JPH0191759A (en) | Gelatinous food | |
Stegink et al. | Effect of starch ingestion on plasma glutamate concentrations in humans ingesting monosodium L-glutamate in soup | |
JP2005350371A (en) | Nutrient composition for hepatopathic patient | |
KR20070095338A (en) | Hepatic function remedial agent | |
JPS63185339A (en) | Composition for food | |
EP1712139A1 (en) | Sustained energy release compositions | |
JP2001233783A (en) | Preoperative nutrient agent | |
JP4611775B2 (en) | Antihypertensive | |
WO1995017199A1 (en) | Novel therapeutic carbohydrate blends useful for aiding sleep disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |